glp 1 drugs and vision loss π Optometrists are warning GLP-1 may pose these types of rare risks π β¬οΈ Details in comments US court centralizes vision-loss lawsuits
Description
GLP1 agonist therapy may be used to address medically supervised weight reduction, obesity-related comorbidities, and longer-term weight management in appropriately evaluated patients

These changes occurred alongside reductions in inflammatory cytokines and adhesion molecules

Concerns regarding pancreatitis have not been substantiated in large cardiovascular outcome trials (92, 93)

The FDA has approved the following GLP-1 medications for heart health

Promising results but caution needed in GLP-1RA large scale epidemiology

If you achieve your goals on semaglutide, perfect
